BiotechTube
Home/Pipeline/SB02

SB02

Solid Tumor Anti‑Angiogenesis

PreclinicalActive

Key Facts

Indication
Solid Tumor Anti‑Angiogenesis
Phase
Preclinical
Status
Active
Company
SynCore Biotechnology

About SynCore Biotechnology

Taiwan‑based public biotech advancing oncology, ophthalmology and dermatology pipelines with Phase‑3 assets.

View full company profile

Therapeutic Areas

OncologyOphthalmologyDermatology